News

A new study gleans troubling findings—four in 10 health care providers choose to go to work despite experiencing symptoms of infectious disease.

Contagion® will be providing exclusive coverage on the conference. Keep your eyes peeled for session coverage and interviews with some of the key presenters.

Recent data demonstrated that small doses of raltegravir could lead patients developing malignancies; however, the observations had not yet been substantiated.

The US Food and Drug Administration (FDA) has cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings.

While a new FDA report shows antibiotic resistance remains low among many food-borne bacteria, some pathogens are increasingly showing multidrug resistance.

Can we track Clostridium difficile infections to see how patient movements result in exposures?

In case you missed them, we've compiled the top five infectious disease articles from this past week.

While rising temperatures and sea levels are often considered, changing climate patterns can have vast implications for epidemic risk as well.

The results of a new study show that prescribing 1 antibiotic to treat community-acquired pneumonia in children may be as effective as the usual 2-antibiotic treatment, in most cases.

Dolutegravir seemed to be a promising maintenance monotherapy for people living with HIV, but the development of resistance mutations in testing strikes it from the list.

A viral hemorrhagic fever is currently plaguing Uganda. We break down the current situation.

A new study has shown that women with schistosomiasis are at greater risk for HIV infection.

Researchers from The Scripps Research Institute have discovered why egg-based influenza vaccines offer a lower level of protection against H3N2 viruses.

What is pharma doing about the impending antibiotic resistance “apocalypse?”

Part 3 of our series looks at

Three antimicrobial susceptibility tests have been cleared by the FDA concurrently with the launch of a new antibiotic Baxdela, to help guide its use.

At this year’s annual CHEST meeting, Theravance Biopharma investigators report positive new data pertaining to VIBATIV gleaned from the TOUR study.

Tuberculosis (TB) remains the #1 infectious killer, worldwide, surpassing HIV / AIDS, according to the latest global TB report from the World Health Organization.

Another prong in the battle against resistant Gram-negative infections is the addition of beta-lactamase inhibitors to restore or improve the activity of older carbapenems.

The plague outbreak in Madagascar appears to be winding down, but will a centuries-old ritual reverse the progress?

Investigators in China have found that the presence of the MCR-1 gene has increased in humans over a period of 5 years.

Antimicrobial-resistant organisms, particularly Gram-negative bacteria, present a critical threat and a substantial burden.

C. difficile prevention is usually thought of in terms of environmental disinfection and health care worker hand hygiene; what about the patient's role?

In case you missed them, we've compiled the top 5 articles from this past week.

After 1 week of treatment, heavily treatment-experienced (HTE) patients who received fotemsavir, added to a failing regimen, had a greater reduction in viral load than patients on placebo.

The CDC’s ACIP recommends newly FDA-approved Shingrix as the preferred vaccine for the prevention of shingles in individuals 50 years of age or older.

Almost 430,000 individuals succumbed to malaria infection in 2015.

In a new study, investigators examine the advantages and drawbacks of using metagenomic next-generation sequencing (mNGS) for the identification of pathogens.